Impact of the definition of time to event endpoint on randomized clinical trials results in oncology (datecan-2): an analysis of 9 pancreatic cancer trials

被引：0
|
作者：
Pam, A. [1 ]
Vernerey, D. [1 ]
Baron, B. [2 ]
Chauffert, B. [3 ]
Louvet, C. [4 ]
Wagener, J. [5 ]
Levi, F. [6 ,7 ]
Hans, S. [8 ]
Trouilloud, I. [9 ]
Jan, J. [10 ]
Van Laethem, J. L. [11 ]
Taieb, J. [9 ]
Haustermans, K. [12 ]
Dahan, L. [13 ]
Dureux, M. [14 ]
Lutz, M. [15 ]
Bellera, C. [16 ]
Gourgou, S. [17 ,18 ]
Anota, A. [1 ]
Bonnetain, F. [1 ]
机构：
[1] CHU Besancon, Doubs, F-25030 Besancon, France
[2] EORTC Data Ctr, Brussels, Belgium
[3] Anticanc Ctr GF Leclerc, Dept Oncol, Dijon, France
[4] Inst Mutualiste Montsouris, Dept Oncol, Paris, France
[5] UMC Nijmegen, Nijmegen, Netherlands
[6] Hop Paul Brousse, Villejuif, France
[7] INSERM, Villejuif, France
[8] Univ Hosp Rotterdam Dijikzigt, Rotterdam, Netherlands
[9] Georges Pompidou European Hosp, Dept Gastroenterol & Digest Oncol, Paris, France
[10] Univ Rotterdam Hosp, Rotterdam, Netherlands
[11] Erasme Univ Hosp, Medicosug Dept Gastroenerol, B-1070 Brussels, Belgium
[12] Univ Hosp Gasthuisberg, Leuven, Leuven, Belgium
[13] Univ Mediterranean, Timone Hosp, Hosp Publ Assistance Marseille, Marseille, France
[14] Inst Gustave Roussy, Gastrointestinal Unit, Villejuif, France
[15] Univ Ulm, D-89069 Ulm, Germany
[16] Inst Bergonie, Ctr Comprehens Canc, Clin & Epidemiol Res Unit, Bordeaux, France
[17] Inst Canc Montpellier, Ctr Comprehens Canc, Montpellier, France
[18] Data Ctr Canc Clin Trials, CTD INCa, Montpellier, France
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31292-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2376
引用
收藏
页码：S462 / S462
页数：1
相关论文
共 50 条
  • [31] Estimating the Treatment Effect in a Subgroup Defined by an Early Post-Baseline Biomarker Measurement in Randomized Clinical Trials With Time-To-Event Endpoint
    Bornkamp, Bjoern
    Bermann, Georgina
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2020, 12 (01): : 19 - 28
  • [32] Time-to-event endpoints in operable non-small-cell lung cancer randomized clinical trials
    Fiteni, Frederic
    Paillard, Marie-Justine
    Westeel, Virginie
    Bonnetain, Franck
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (02) : 167 - 173
  • [33] INDIVIDUAL PATIENT DATA ANALYSIS IN RANDOMIZED CLINICAL TRIALS: IMPACT OF RACE ON PROSTATE CANCER OUTCOMES
    Spratt, Daniel
    Chen, Yu-Wei
    Mahal, Brandon
    Osborne, Joseph
    Zhao, Shuang
    Morgan, Todd
    Palapattu, Ganesh
    Feng, Felix
    Nguyen, Paul
    JOURNAL OF UROLOGY, 2016, 195 (04): : E499 - E499
  • [34] Assessing patient-reported outcomes (PROs) and patient-related outcomes in randomized cancer clinical trials for older adults: Results of DATECAN-ELDERLY initiative
    Soubeyran, Pierre
    Brain, Etienne
    Cheung, Kwok-Leung
    Hamaker, Marije E.
    Kanesvaran, Ravindran
    Mauer, Murielle
    Mohile, Supriya
    Montroni, Isacco
    Puts, Martine
    Rostoft, Siri
    Wildiers, Hans
    Mathoulin-Pelissier, Simone
    Bellera, Carine
    JOURNAL OF GERIATRIC ONCOLOGY, 2024, 15 (01)
  • [35] Evaluating the financial impact of clinical trials in oncology: Results from a pilot study from the association of American Cancer Institutes/Northwestern University Clinical Trials Costs and Charges Project
    Bennett, CL
    Stinson, TJ
    Vogel, V
    Robertson, L
    Leedy, D
    O'Brien, P
    Hobbs, J
    Sutton, T
    Ruckdeschel, JC
    Chirikos, TN
    Weiner, RS
    Ramsey, MM
    Wicha, MS
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (15) : 2805 - 2810
  • [36] Real-world impact of surgical clinical trials in gynecological oncology: an interrupted time series analysis in France
    Jochum, Floriane
    Doll, Madeleine
    Laas, Enora
    Lecointre, Lise
    Reyal, Fabien
    Akladios, Cherif
    Lecuru, Fabrice
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A47 - A47
  • [37] Adjuvant therapy in resected pancreatic cancer: A systematic review of literature with meta-analysis of randomized clinical trials
    Drudi, Fabrizio
    Tassinari, Davide
    Ridolfi, Claudio
    Affatato, Alessandra
    Tamburini, Emiliano
    Santelmo, Carlotta
    Carloni, Federica
    Gianni, Lorenzo
    Veneroni, Luigi
    Donati, Gabriele
    Ravaioli, Alberto
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [38] Progression-free survival as surrogate endpoint in advanced pancreatic cancer: meta-analysis of 30 randomized first-line trials
    Petrelli, Fausto
    Coinu, Andrea
    Borgonovo, Karen
    Cabiddu, Mary
    Barni, Sandro
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (02) : 124 - 131
  • [39] Progression-free survival as surrogate endpoint in advanced pancreatic cancer: meta-analysis of 30 randomized first-line trials
    Fausto Petrelli
    Andrea Coinu
    Karen Borgonovo
    Mary Cabiddu
    Sandro Barni
    Hepatobiliary & Pancreatic Diseases International, 2015, 14 (02) : 124 - 131
  • [40] Impact of QRS Duration on Clinical Event Reduction with Cardiac Resynchronization Therapy: A Meta-Analysis of Randomized Controlled Trials
    Sipahi, Ilke
    Carrigan, Thomas P.
    Rowland, Douglas Y.
    Stambler, Bruce S.
    Fang, James C.
    CIRCULATION, 2010, 122 (21)
12345